A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

Clinical trial NCT00787150 · COMPLETED

Trial details

NCT number: NCT00787150
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2008-06-01
Primary completion: 2009-09-01
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.